GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » Market Cap

Taiwan Bio Therapeutics Co (ROCO:6892) Market Cap : NT$3,119.8 Mil (As of Oct. 31, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Taiwan Bio Therapeutics Co's share price for the quarter that ended in Jun. 2024 was NT$40.8402. Taiwan Bio Therapeutics Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 74.5 Mil. Therefore, Taiwan Bio Therapeutics Co's market cap for the quarter that ended in Jun. 2024 was NT$3,044.6 Mil.

Taiwan Bio Therapeutics Co's quarterly market cap declined from Jun. 2023 (NT$2,341.6 Mil) to Dec. 2023 (NT$2,109.8 Mil) but then increased from Dec. 2023 (NT$2,109.8 Mil) to Jun. 2024 (NT$3,044.6 Mil).

Taiwan Bio Therapeutics Co's annual market cap increased from Dec. 2021 (NT$0.0 Mil) to Dec. 2022 (NT$1,638.6 Mil) and increased from Dec. 2022 (NT$1,638.6 Mil) to Dec. 2023 (NT$2,109.8 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Taiwan Bio Therapeutics Co's Enterprise Value for Today is NT$2,943.2 Mil.


Taiwan Bio Therapeutics Co Market Cap Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co Market Cap Chart

Taiwan Bio Therapeutics Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 1,638.59 2,109.83

Taiwan Bio Therapeutics Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only - 1,638.59 2,341.57 2,109.83 3,044.58

Competitive Comparison of Taiwan Bio Therapeutics Co's Market Cap

For the Biotechnology subindustry, Taiwan Bio Therapeutics Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Bio Therapeutics Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics Co's Market Cap falls into.



Taiwan Bio Therapeutics Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Taiwan Bio Therapeutics Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$33.7561*62.5023
=NT$2,109.8

Taiwan Bio Therapeutics Co's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$40.8402*74.5485
=NT$3,044.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Bio Therapeutics Co  (ROCO:6892) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Taiwan Bio Therapeutics Co Market Cap Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Bio Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co Headlines

No Headlines